Continuous Bioprocessing Market Size, Share, By Product (Filtration, Chromatography, Bioreactor, Buffers & Reagents, and Others), By Process (Upstream and Downstream), By Application (Monoclonal Antibodies, Vaccines, Plasma Fractionation, and R&D), By End-User (Pharmaceutical & Biotechnology Companies, CDMOs & CROs, and Academic & Research Institutes) and Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) - Trends, Analysis, and Forecast till 2034

Growing demand for biopharmaceuticals:

• Around the world, there is a sharp increase in demand for biopharmaceuticals, which include innovative drugs like gene therapies and effective cures for long-term ailments. Traditional batch processing methods, while well-established, need help to keep up with this increasing demand. Continuous bioprocessing offers significant benefits. Seamlessly combining all manufacturing processes into a single, constant flow significantly boosts productivity over the stop-start cycles of batch processing.
• One example would be a biofactory that continuously creates life-saving drugs instead of waiting till a batch is finished before starting a new one. This leads to a significant increase in the number of drugs that may be manufactured, allowing producers to meet the growing needs of patients worldwide.